{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:07:39Z","timestamp":1773637659582,"version":"3.50.1"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100015034","name":"Research and Technology Department of Shahid Sadoughi University of Medical Sciences, Yazd, Iran","doi-asserted-by":"publisher","award":["7653"],"award-info":[{"award-number":["7653"]}],"id":[{"id":"10.13039\/501100015034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RAIAD"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Timolol is a beta-adrenergic blocker that has been shown to be effective\nin the healing of wounds. Oral mucositis (OM), an acute inflammation of the oral mucosa, is a\nbothersome side effect of some regimens of chemotherapy in which the oral mucosa becomes ulcerated. The current study aimed to evaluate the prophylactic effects of timolol mouthwash in preventing OM in adult patients receiving chemotherapy compared to the placebo<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This randomized, double-blind trial was conducted on 30 adult patients receiving chemotherapy regimen, including doxorubicin or 5-fluorouracil (5-FU). The patients were randomized in a 1:1 ratio to receive either timolol 0.5% (w\/v) (n = 15) or placebo (n = 15) mouthwash 5 ml three times per day. The outcomes of the study were the intensity of OM evaluated by\nthe World Health Organization (WHO) mucositis scale and OM-related pain based on the Visual\nAnalog Scale (VAS) weekly during the seven weeks of the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The results of the study showed that the scores of WHO mucositis scale significantly decreased in the timolol group compared to the control group during the study [week 1: mean (SD),\n0.02 (0.41) in the timolol group, and 0.67 (0.48) in the control group; week 7: mean (SD), 0.33\n(0.61) in the timolol group, and 0.87 (0.74) in the control group; P-value = 0.049]. Moreover, the\nmean pain scores significantly decreased in the first, second, and third weeks in the timolol group\ncompared to the control group (P-value &lt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The results of this preliminary clinical trial demonstrated that among the patients receiving doxorubicin or 5-FU chemotherapy regimens, the preventive use of timolol mouthwash\nsignificantly diminished the severity of OM compared to the control group during the seven\nweeks of follow-up. The severity of pain was also significantly lower during the first three weeks\nof the study; however, the effect size was less than the minimal clinically important difference.\nFurther studies are required to assess both the long-term efficacy and safety of timolol mouthwash\nin preventing OM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0127722708312485250115052258","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:10:38Z","timestamp":1737951038000},"page":"89-99","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevention of Chemotherapy-related Oral Mucositis by Topical Timolol: A Prospective Randomized, Double-blind, Placebo-controlled Clinical Trial in Cancer Patients"],"prefix":"10.2174","volume":"20","author":[{"given":"Fatemeh","family":"Saghafi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Shahid Sadoughi University of Medical Sciences and HealthServices, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Shaker-Ardakani","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Research Center, School of Pharmacy, Shahid Sadoughi University ofMedical Sciences and Health Services, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Nabi-Meybodi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan-Ali","family":"Vahedian-Ardakani","sequence":"additional","affiliation":[{"name":"Department of Oncology, School of Medicine,Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeleh","family":"Sahebnasagh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Clinical Research Center, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrc.2017.93","volume":"17","author":"Dewhirst M.W.","year":"2017","unstructured":"Dewhirst M.W.; Secomb T.W.; Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer  2017,17(12),738-750","journal-title":"Nat Rev Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12906-020-02935-2","volume":"20","author":"Sahebnasagh A","year":"2020","unstructured":"Sahebnasagh A; Ghasemi A; Akbari J; Alipour A; Lashkardoost H; Ala S; Prevention of acute radiation-induced Proctitis by Aloe vera: A prospective randomized, double-blind, placebo controlled clinical trial in Pelvic Cancer patients. BMC Complement Med Ther  2020,20(1),146","journal-title":"BMC Complement Med Ther"},{"key":"ref=4","first-page":"34","volume":"76","author":"Scardina G.A.","year":"2010","unstructured":"Scardina G.A.; Pisano T.; Messina P.; Oral mucositis. Review of literature. N Y State Dent J  2010,76(1),34-38","journal-title":"N Y State Dent J"},{"key":"ref=5","author":"Redman M.G.","year":"2021","unstructured":"Redman M.G.; Harris K.; Phillips B.S.; Low-level laser therapy for oral mucositis in children with cancer. Arch Dis Child  2021","journal-title":"Arch Dis Child"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"101300","DOI":"10.1016\/j.disamonth.2021.101300","volume":"68","author":"Shetty S.S.","year":"2022","unstructured":"Shetty S.S.; Maruthi M.; Dhara V.; de Arruda J.A.A.; Abreu L.G.; Mesquita R.A.; Teixeira A.L.; Silva T.A.; Merchant Y.; Oral mucositis: Current knowledge and future directions. Dis Mon  2022,68(5),101300","journal-title":"Dis Mon"},{"key":"ref=7","first-page":"4","volume":"15","author":"Biswal B.M.","year":"2008","unstructured":"Biswal B.M.; Current trends in the management of oral mucositis related to cancer treatment. Malays J Med Sci  2008,15(3),4-13","journal-title":"Malays J Med Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"105296","DOI":"10.1016\/j.oraloncology.2021.105296","volume":"118","author":"Rodrigues-Oliveira L.","year":"2021","unstructured":"Rodrigues-Oliveira L.; Kowalski L.P.; Santos M.; Marta G.N.; Bensadoun R.J.; Martins M.D.; Lopes M.A.; Castro G.; William W.N.; Chaves A.L.F.; Migliorati C.A.; Salloum R.G.; Rodrigues-Fernandes C.I.; Kauark-Fontes E.; Brand\u00e3o T.B.; Santos-Silva A.R.; Prado-Ribeiro A.C.; Direct costs associated with the management of mucositis: A systematic review. Oral Oncol  2021,118,105296","journal-title":"Oral Oncol"},{"key":"ref=9","volume":"6","author":"Jayakeerthana S.","year":"2021","unstructured":"Jayakeerthana S.; Awareness of night brushing among local population. Int J Sci Dev Res  2021,6(3)","journal-title":"Int J Sci Dev Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.3390\/ijms23094863","volume":"23","author":"Nguyen H.","year":"2022","unstructured":"Nguyen H.; Sangha S.; Pan M.; Shin D.H.; Park H.; Mohammed A.I.; Cirillo N.; Oxidative stress and chemoradiation-induced oral mucositis: A scoping review of in vitro and in vivo and clinical studies. Int J Mol Sci  2022,23(9),4863","journal-title":"Int J Mol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/njms.NJMS_10_20","volume":"11","author":"Singh V.","year":"2020","unstructured":"Singh V.; Singh A.; Oral mucositis. Natl J Maxillofac Surg  2020,11(2),159-168","journal-title":"Natl J Maxillofac Surg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cden.2007.10.002","volume":"52","author":"Lalla R.V.","year":"2008","unstructured":"Lalla R.V.; Sonis S.T.; Peterson D.E.; Management of oral mucositis in patients who have cancer. Dent Clin North Am  2008,52(1),61-77, viii","journal-title":"Dent Clin North Am"},{"key":"ref=13","author":"Supportive P.","year":"2016","unstructured":"Supportive P.; Board P.C.E.; Oral complications of chemotherapy and head\/neck radiation (PDQ\u00ae). PDQ Cancer Information Summaries  2016","journal-title":"PDQ Cancer Information Summaries"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e0253139","DOI":"10.1371\/journal.pone.0253139","volume":"16","author":"Yang H.","year":"2021","unstructured":"Yang H.; Steenhuis P.; Glucksman A.M.; Gurenko Z.; La T.D.; Isseroff R.R.; Alpha and beta adrenergic receptors modulate keratinocyte migration. PLoS One  2021,16(7),e0253139","journal-title":"PLoS One"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jvsv.2017.04.019","volume":"5","author":"Thomas B.","year":"2017","unstructured":"Thomas B.; Kurien J.S.; Jose T.; Ulahannan S.E.; Varghese S.A.; Topical timolol promotes healing of chronic leg ulcer. J Vasc Surg Venous Lymphat Disord  2017,5(6),844-850","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.phrs.2008.07.012","volume":"58","author":"Pullar C.","year":"2008","unstructured":"Pullar C.; Manabathidalgo C.; Bolaji R.; Isseroff R.; \u03b2-Adrenergic receptor modulation of wound repair. Pharmacol Res  2008,58(2),158-164","journal-title":"Pharmacol Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e14847","DOI":"10.1111\/dth.14847","volume":"34","author":"Goodarzi A.","year":"2021","unstructured":"Goodarzi A.; Mozafarpoor S.; Dodangeh M.; Seirafianpour F.; Shahverdi M.H.; The role of topical timolol in wound healing and the treatment of vascular lesions: A narrative review. Dermatol Ther  2021,34(2),e14847","journal-title":"Dermatol Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/jid.2012.108","volume":"132","author":"Pullar C.E.","year":"2012","unstructured":"Pullar C.E.; Le Provost G.S.; O\u2019Leary A.P.; Evans S.E.; Baier B.S.; Rivkah Isseroff R.; \u03b22AR antagonists and \u03b22AR gene deletion both promote skin wound repair processes. J Invest Dermatol  2012,132(8),2076-2084","journal-title":"J Invest Dermatol"},{"key":"ref=19","first-page":"283","volume":"111","author":"Migliazzo C.V.","year":"2014","unstructured":"Migliazzo C.V.; Hagan J.C.; Beta blocker eye drops for treatment of acute migraine. Mo Med  2014,111(4),283-288","journal-title":"Mo Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"21225","DOI":"10.1074\/jbc.M601007200","volume":"281","author":"Pullar C.E.","year":"2006","unstructured":"Pullar C.E.; Rizzo A.; Isseroff R.R.; \u03b2-Adrenergic receptor antagonists accelerate skin wound healing: Evidence for a catecholamine synthesis network in the epidermis. J Biol Chem  2006,281(30),21225-21235","journal-title":"J Biol Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1016\/j.bmc.2006.02.023","volume":"14","author":"Gomes A.","year":"2006","unstructured":"Gomes A.; Costa D.; Lima J.L.F.C.; Fernandes E.; Antioxidant activity of \u03b2-blockers: An effect mediated by scavenging reactive oxygen and nitrogen species? Bioorg Med Chem  2006,14(13),4568-4577","journal-title":"Bioorg Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/1567201813666151123103354","volume":"13","author":"Turan B.","year":"2016","unstructured":"Turan B.; A comparative summary on antioxidant-like actions of timolol with other antioxidants in diabetic cardiomyopathy. Curr Drug Deliv  2016,13(3),418-423","journal-title":"Curr Drug Deliv"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.2147\/OTT.S96899","volume":"9","author":"Kwon Y.","year":"2016","unstructured":"Kwon Y.; Mechanism-based management for mucositis: Option for treating side effects without compromising the efficacy of cancer therapy. OncoTargets Ther  2016,9,2007-2016","journal-title":"OncoTargets Ther"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.eye.6702737","volume":"22","author":"Izzotti A.","year":"2008","unstructured":"Izzotti A.; Sacc\u00e0 S.C.; Di Marco B.; Penco S.; Bassi A.M.; Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course. Eye (Lond)  2008,22(3),445-453","journal-title":"Eye (Lond)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fonc.2018.00605","volume":"8","author":"Wu H.W.","year":"2018","unstructured":"Wu H.W.; Wang X.; Zhang L.; Zheng J.W.; Liu C.; Wang Y.A.; Topical timolol vs. oral propranolol for the treatment of superficial infantile hemangiomas. Front Oncol  2018,8,605","journal-title":"Front Oncol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3892\/ol.2016.4818","volume":"12","author":"Tong S.","year":"2016","unstructured":"Tong S.; Xu D.P.; Liu Z.M.; Du Y.; Wang X.K.; Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas. Oncol Lett  2016,12(3),1806-1810","journal-title":"Oncol Lett"},{"key":"ref=27","first-page":"196","author":"Bahramsoltani R.","year":"2017","unstructured":"Bahramsoltani R.; Medicinal plants for chemoradiotherapy-induced oral mucositis: A review of clinical studies. J Trad Integrative Med  2017,196-207","journal-title":"J Trad Integrative Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"8663210","DOI":"10.1155\/2021\/8663210","volume":"2021","author":"Owusu-Boadi E","year":"2021","unstructured":"Owusu-Boadi E; Akuoko Essuman M; Mensah G; Ayamba Ayimbissa E; Boye A.; Antimicrobial activity against oral pathogens confirms the use of musa paradisiaca fruit stalk in ethnodentistry. Evid Based Complement Alternat Med  2021,2021,8663210","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"100929","DOI":"10.1016\/j.eujim.2019.100929","volume":"29","author":"Seyed Hashemi M.","year":"2019","unstructured":"Seyed Hashemi M.; Hashempur M.H.; Lotfi M.H.; Hemat H.; Mousavi Z.; Emtiazy M.; Vaziri F.; The efficacy of asafoetida (Ferula assa-foetida oleo-gum resin) versus chlorhexidine gluconate mouthwash on dental plaque and gingivitis: A randomized double-blind controlled trial. Eur J Integr Med  2019,29,100929","journal-title":"Eur J Integr Med"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"5548404","DOI":"10.1155\/2021\/5548404","volume":"2021","author":"Mousavi SM","year":"2021","unstructured":"Mousavi SM; Hashemi SA; Behbudi G; Mazraedoost S; Omidifar N; Gholami A; A Review on health benefits of Malva sylvestris L. nutritional compounds for metabolites, antioxidants, and anti-inflammatory, anticancer, and antimicrobial applications. Evid Based Complement Alternat Med  2021,2021,5548404","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"614877","DOI":"10.3389\/fonc.2021.614877","volume":"11","author":"Agha-Hosseini F.","year":"2021","unstructured":"Agha-Hosseini F.; Pourpasha M.; Amanlou M.; Moosavi M.S.; Mouthwash containing vitamin E, Triamcinolon, and Hyaluronic Acid compared to triamcinolone mouthwash alone in patients with radiotherapy-induced oral mucositis: Randomized clinical trial. Front Oncol  2021,11,614877","journal-title":"Front Oncol"},{"key":"ref=32","volume":"9","author":"Gilani SA","year":"2021","unstructured":"Gilani SA; Gilani NA; Feroz F; Faizan M; Murtaza G; Combination of Chlorhexidine with magic mouth wash for the prophylaxes of chemotherapy induced mucositis. Global Sci J  2021,9(5)","journal-title":"Global Sci J"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"627628","DOI":"10.3389\/fphar.2021.627628","volume":"12","author":"Lin Z.","year":"2021","unstructured":"Lin Z.; Chen J.; Han S.; The efficacy of heat-clearing (Qingre) and Detoxifying (Jiedu) traditional chinese medicine gargle for chemotherapy-induced oral mucositis: A systematic review and meta-analysis. Front Pharmacol  2021,12,627628","journal-title":"Front Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"284959","DOI":"10.1155\/2013\/284959","volume":"2013","author":"Meyer-Hamme G","year":"2013","unstructured":"Meyer-Hamme G; Beckmann K; Radtke J; Efferth T; Greten HJ; Rostock M; A survey of chinese medicinal herbal treatment for chemotherapy-induced oral mucositis. Evid Based Complement Alternat Med  2013,2013,284959","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=35","author":"Aulton ME","year":"2013","unstructured":"Aulton ME; Taylor K;  Aulton's pharmaceutics: The design and manufacture of medicines  2013","journal-title":"Aulton's pharmaceutics: The design and manufacture of medicines"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/JAMMR\/2017\/37603","volume":"24","author":"Metwaly HAM","year":"2017","unstructured":"Metwaly HAM; Ebrahem MA-M; Hussein FF; Evaluation of the efficacy of topical timolol therapy on oral lichen planus: Clinical and immunohistochemical study. J adv med  2017,24(8),1-13","journal-title":"J adv med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cis.2009.05.003","volume":"158","author":"Nystr\u00f6m B.","year":"2010","unstructured":"Nystr\u00f6m B.; Kj\u00f8niksen A.L.; Beheshti N.; Maleki A.; Zhu K.; Knudsen K.D.; Pamies R.; Hern\u00e1ndez Cifre J.G.; Garc\u00eda de la Torre J.; Characterization of polyelectrolyte features in polysaccharide systems and mucin. Adv Colloid Interface Sci  2010,158(1-2),108-118","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=38","first-page":"287","volume":"4","author":"Julious S.A.","year":"2005","unstructured":"Julious S.A.; Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics. J Appl Stat  2005,4(4),287-291","journal-title":"J Appl Stat"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2288-4-26","volume":"4","author":"Saghaei M.","year":"2004","unstructured":"Saghaei M.; Random allocation software for parallel group randomized trials. BMC Med Res Methodol  2004,4(1),26","journal-title":"BMC Med Res Methodol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1601-0825.2006.01258.x","volume":"12","author":"Scully C.","year":"2006","unstructured":"Scully C.; Sonis S.; Diz P.D.; Oral mucositis. Oral Dis  2006,12(3),229-241","journal-title":"Oral Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fonc.2017.00089","volume":"7","author":"Maria O.M.","year":"2017","unstructured":"Maria O.M.; Eliopoulos N.; Muanza T.; Radiation-induced oral mucositis. Front Oncol  2017,7,89","journal-title":"Front Oncol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cncr.28592","volume":"120","author":"Lalla R.V.","year":"2014","unstructured":"Lalla R.V.; Bowen J.; Barasch A.; Elting L.; Epstein J.; Keefe D.M.; McGuire D.B.; Migliorati C.; Nicolatou-Galitis O.; Peterson D.E.; Raber-Durlacher J.E.; Sonis S.T.; Elad S.; MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer  2014,120(10),1453-1461","journal-title":"Cancer"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"vi78","DOI":"10.1093\/annonc\/mdr391","volume":"22","author":"Peterson D.E.","year":"2011","unstructured":"Peterson D.E.; Bensadoun R.J.; Roila F.; Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Ann Oncol  2011,22(Suppl 6)(Suppl. 6),vi78-vi84","journal-title":"Ann Oncol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1007\/s00520-021-06247-0","volume":"29","author":"Eubank P.L.C.","year":"2021","unstructured":"Eubank P.L.C.; Abreu L.G.; Violante I.P.; Volpato L.E.R.; Medicinal plants used for the treatment of mucositis induced by oncotherapy: A systematic review. Support Care Cancer  2021,29(11),6981-6993","journal-title":"Support Care Cancer"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1534735420940412","DOI":"10.1177\/1534735420940412","volume":"20","author":"Steinmann D.","year":"2021","unstructured":"Steinmann D.; Babada\u011f Sava\u015f B.; Felber S.; Joy S.; Mertens I.; Cramer H.; Paul A.; Layer M.; Klafke N.; Stolz R.; Heyder U.; Neuberger P.; Winkler M.; Idler C.; Heine R.; Kaschdailewitsch E.; John H.; Schmeling B.; Zielke T.; Horneber M.; Witt C.M.; Voiss P.; Nursing procedures for the prevention and treatment of mucositis induced by cancer therapies: Clinical practice guideline based on an interdisciplinary consensus process and a systematic literature search. Integr Cancer Ther  2021,20,1534735420940412","journal-title":"Integr Cancer Ther"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/hed.10318","volume":"25","author":"Scully C.","year":"2003","unstructured":"Scully C.; Epstein J.; Sonis S.; Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: Part 1, pathogenesis and prophylaxis of mucositis. Head Neck  2003,25(12),1057-1070","journal-title":"Head Neck"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s13671-024-00421-3","volume":"13","author":"Lyle R.E.","year":"2024","unstructured":"Lyle R.E.; Budhiraja A.; Mehta A.; Dahle S.E.; Isseroff R.R.; The use of timolol for wound healing\u2014A review. Curr Dermatol Rep  2024,13(1),8-27","journal-title":"Curr Dermatol Rep"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/med.21984","volume":"44","author":"Jia S.","year":"2024","unstructured":"Jia S.; Wang X.; Wang G.; Wang X.; Mechanism and application of \u03b2\u2010adrenoceptor blockers in soft tissue wound healing. Med Res Rev  2024,44(1),422-452","journal-title":"Med Res Rev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1524-4725.2011.02200.x","volume":"38","author":"Tang J.C.","year":"2012","unstructured":"Tang J.C.; Dosal J.; Kirsner R.S.; Topical timolol for a refractory wound. Dermatol Surg  2012,38(1),135-138","journal-title":"Dermatol Surg"},{"key":"ref=50","first-page":"E27","volume":"100","author":"Dabiri G.","year":"2017","unstructured":"Dabiri G.; Tiger J.; Goreshi R.; Fischer A.; Iwamoto S.; Topical timolol may improve overall scar cosmesis in acute surgical wounds. Cutis  2017,100(1),E27-E28","journal-title":"Cutis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/pbc.20863","volume":"49","author":"Sung L.","year":"2007","unstructured":"Sung L.; Tomlinson G.A.; Greenberg M.L.; Koren G.; Judd P.; Ota S.; Feldman B.M.; Validation of the oral mucositis assessment scale in pediatric cancer. Pediatr Blood Cancer  2007,49(2),149-153","journal-title":"Pediatr Blood Cancer"}],"container-title":["Recent Advances in Inflammation &amp; Allergy Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127722708312485250115052258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/238835\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127722708312485250115052258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T04:10:35Z","timestamp":1773634235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/238835\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0127722708312485250115052258","relation":{},"ISSN":["2772-2708"],"issn-type":[{"value":"2772-2708","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}